News BioTalk – Revolutionizing Autoimmune Medicine: MyMD Pharmaceuticals Innovative Therapies Are you interested in exploring cutting-edge autoimmune medicines? In this episode of BioTalk with Rich Bendis, we're delving deep into…AndyOctober 15, 2023
BioTalk with Rich Bendis Podcast BioTalk – Revolutionizing Autoimmune Medicine: MyMD Pharmaceuticals Innovative Therapies Are you interested in exploring cutting-edge autoimmune medicines? In this episode of BioTalk with Rich Bendis, we're delving deep into…AndyOctober 15, 2023
News Governor Moore Spotlights Biotechnology and Economic Development During Visit to University of Maryland BioPark Published: 10/10/2023 ANNAPOLIS, MD — Governor Wes Moore today visited the University of Maryland BioPark for a discussion and tour focused…AndyOctober 12, 2023
News IndoUSrare Announces Bridging RARE Summit to Combat Rare Diseases by Fostering Cross-Border Collaborations, Data Sharing, and Clinical Trials With an increasing number of U.S. biopharmaceutical firms feeling the financial constraints imposed by the Inflation Reduction Act (IRA) and…AndyOctober 9, 2023
News Emmes Acquires VaxTRIALS VaxTRIALS Adds a New Latin America Base and Greater Vaccine Research Depth Rockville, MD, October 5, 2023 – Emmes, a…AndyOctober 9, 2023
News Maryland based United Therapeutics is leading a medical revolution Imagine a world where unhealthy organs are replaced with transplants constructed with a 3D printer using the patient’s own cells.…AndyOctober 9, 2023
News Navigating 2023’s BioPharma Clusters with Alex Philippidis Alex Philippidis, Senior Business Editor of Genetic Engineering and Biotechnology News, for the 4th consecutive year, attended the 9th Annual…AndyOctober 9, 2023
News Unveiling Key Insights with Pete Briskman: A Comprehensive Update on the BioHealth Capital Region In the 9th Annual BioHealth Capital Region Forum, Pete Briskman, Executive Managing Director and Co-Lead for the Mid-Atlantic Life Sciences…AndyOctober 9, 2023
News Amgen Completes Acquisition of Horizon Therapeutics PLC Advances Amgen's Mission to Serve Patients With First-in-Class Rare Disease Medicines THOUSAND OAKS, Calif., Oct. 6, 2023 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that it…AndyOctober 6, 2023
News Revisiting Rich Bendis’s Welcome at the 9th Annual BioHealth Capital Region Forum In a year that underscored “Global Breakthroughs for a Healthier Future,” Rich Bendis, President and CEO of BioHealth Innovation Inc…AndyOctober 6, 2023